Company profile: Affinium Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical research and development focused on novel anti-infective medicines, advancing FASII antibacterial programs as a new antibiotic franchise with potential for multiple products targeting the FASII pathway, supported by a broad base of long-term intellectual property.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Affinium Pharmaceuticals
NanoViricides
HQ: United States
Website
- Description: Provider of nanomedicine-based antiviral therapeutics, developing broad-spectrum candidates including NV-387 (RSV, smallpox, mpox, influenza A), NV-CoV-2 for COVID-19 and potentially long COVID (Phase 1a/1b), NV-CoV-2-R with remdesivir, and NV-HHV-1 for shingles rash, leveraging the TheraCour platform and the HerpeCide program for herpes infections (cold sores, genital ulcers, keratitis).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoViricides company profile →
Abivax
HQ: France
Website
- Description: Provider of clinical-stage biotechnology therapies that mobilize the body's natural immune machinery to treat autoimmune diseases, viral infections, and cancer, including obefazimod for ulcerative colitis (Phase 3), planned Phase 2b for Crohn's disease, exploration as combination therapy for ulcerative colitis in preclinical studies, and nonclinical evaluation for additional chronic inflammatory indications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abivax company profile →
iosBio
HQ: United Kingdom
Website
- Description: Provider of thermally stable oral vaccine platforms and services, offering vaccine manufacturing, distribution, and delivery. Its OraPro technology uses viral vectors to deliver capsule-based vaccines to the GI tract, enabling mucosal and systemic immunity without cold-chain storage. Products include OraPro and OraPro-Covid-19, an at-home oral vaccine targeting S and N proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iosBio company profile →
Oxsed
HQ: United Kingdom
Website
- Description: Provider of accurate and rapid testing worldwide to minimize the impact of disease on individuals and communities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oxsed company profile →
Coulter Pharmaceutical
HQ: United States
Website
- Description: Provider of immunotherapeutics aimed at treating and preventing autoimmune diseases, cancer, and infectious diseases by understanding and directing the immune system; conducted preclinical development programs including the BEXXAR therapy and MELACINE vaccine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coulter Pharmaceutical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Affinium Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Affinium Pharmaceuticals
2.2 - Growth funds investing in similar companies to Affinium Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Affinium Pharmaceuticals
4.2 - Public trading comparable groups for Affinium Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →